Ohio Valley Financial Group Cut Altria Group (MO) Stake as Shares Declined; Gilead Sciences Com (GILD) Stake Boosted by Muhlenkamp & Co Inc

August 12, 2018 - By Matthew Richard

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Muhlenkamp & Co Inc increased its stake in Gilead Sciences Inc Com (GILD) by 800.31% based on its latest 2018Q1 regulatory filing with the SEC. Muhlenkamp & Co Inc bought 197,677 shares as the company’s stock declined 17.62% with the market. The institutional investor held 222,377 shares of the health care company at the end of 2018Q1, valued at $16.77M, up from 24,700 at the end of the previous reported quarter. Muhlenkamp & Co Inc who had been investing in Gilead Sciences Inc Com for a number of months, seems to be bullish on the $99.47B market cap company. The stock decreased 1.68% or $1.31 during the last trading session, reaching $76.73. About 4.83 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 4.37% since August 12, 2017 and is uptrending. It has underperformed by 8.20% the S&P500. Some Historical GILD News: 30/05/2018 – GALAPAGOS NV – EQUATOR ACHIEVES PRIMARY ENDPOINT OF ACR20 RESPONSE AT WEEK 16; 06/03/2018 – GILEAD SCIENCES INC GILD.O : BARCLAYS RAISES TARGET PRICE TO $95 FROM $90; 08/05/2018 – UK biotech firm Autolus joins CAR-T rush with Nasdaq IPO filing; 06/03/2018 – Top 3 — #1 Searching for HIV cure, Gilead’s new ‘shock and kill’ combo swats back lethal virus in monkeys $GILD; 27/04/2018 – Gilead’s Biktarvy Gets Positive Recommendation in Europe; 25/04/2018 – GILEAD HAD BEEN SUED BY MERCK OVER ITS HEPATITIS DRUGS; 25/04/2018 – Novartis, Gilead to Get Extra Medicare Coverage for Costly Drugs; 13/04/2018 – GILEAD EXPECTS DATA FROM PHASE 3 STELLAR STUDIES IN 1H 2019; 30/04/2018 – Gilead’s Descovy Falls For 2nd Wk, Odefsey Declines: HIV; 18/04/2018 – ASTELLAS PHARMA INC – ASSET TRANSFER WAS COMPLETED ON APRIL 12, 2018

Ohio Valley Financial Group decreased its stake in Altria Group Inc (MO) by 71.75% based on its latest 2018Q1 regulatory filing with the SEC. Ohio Valley Financial Group sold 11,047 shares as the company’s stock declined 14.98% with the market. The institutional investor held 4,350 shares of the farming and seeds and milling company at the end of 2018Q1, valued at $271,000, down from 15,397 at the end of the previous reported quarter. Ohio Valley Financial Group who had been investing in Altria Group Inc for a number of months, seems to be less bullish one the $111.32B market cap company. The stock decreased 0.29% or $0.17 during the last trading session, reaching $59.05. About 4.28M shares traded. Altria Group, Inc. (NYSE:MO) has declined 24.97% since August 12, 2017 and is downtrending. It has underperformed by 37.54% the S&P500.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead: Is The Drama Over?” on August 01, 2018, also Seekingalpha.com with their article: “Gilead’s Stock Price Is Ready To Soar” published on July 30, 2018, Seekingalpha.com published: “What We Can Expect From Gilead” on July 25, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead: A Bell Tolls, And A Window Of Opportunity Opens” published on August 06, 2018 as well as Fool.com‘s news article titled: “Is Gilead Sciences’ Sudden Change in Leadership a Good Thing?” with publication date: July 30, 2018.

Among 32 analysts covering Gilead Sciences (NASDAQ:GILD), 22 have Buy rating, 0 Sell and 10 Hold. Therefore 69% are positive. Gilead Sciences had 135 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Overweight” rating by PiperJaffray on Thursday, May 31. The firm earned “Hold” rating on Thursday, July 27 by Maxim Group. Piper Jaffray initiated Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, May 30 with “Buy” rating. The firm earned “Hold” rating on Friday, April 29 by Maxim Group. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Equal-Weight” rating by Morgan Stanley on Wednesday, May 2. On Friday, October 27 the stock rating was maintained by Jefferies with “Hold”. The company was maintained on Tuesday, July 25 by Piper Jaffray. Bank of America maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, October 4 with “Neutral” rating. As per Wednesday, May 2, the company rating was maintained by RBC Capital Markets. Leerink Swann maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Thursday, October 5 with “Market Perform” rating.

Since February 9, 2018, it had 0 buys, and 17 insider sales for $25.62 million activity. 50,000 shares were sold by MARTIN JOHN C, worth $3.54M on Monday, July 2. WILSON GAYLE E also sold $4.68M worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares. On Thursday, March 1 Alton Gregg H sold $1.97M worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 25,000 shares. $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares were sold by Washington Robin L.

Investors sentiment increased to 0.88 in 2018 Q1. Its up 0.08, from 0.8 in 2017Q4. It improved, as 71 investors sold GILD shares while 519 reduced holdings. 114 funds opened positions while 404 raised stakes. 976.44 million shares or 0.39% more from 972.68 million shares in 2017Q4 were reported. Thompson Siegel And Walmsley Lc owns 151,710 shares. Sva Plumb Wealth Mngmt Limited Com reported 2,720 shares or 0.03% of all its holdings. Kings Point Capital Management invested in 0.01% or 400 shares. Btr Mgmt reported 0.54% in Gilead Sciences, Inc. (NASDAQ:GILD). Tiaa Cref Invest Management Limited Liability Corporation holds 0.37% or 7.31 million shares in its portfolio. Cubist Systematic Strategies Limited Liability Corporation, a Connecticut-based fund reported 17,215 shares. Bb&T has invested 0.33% in Gilead Sciences, Inc. (NASDAQ:GILD). 233,000 were accumulated by Bp Public Limited. Moreover, Dowling Yahnke Ltd Liability Com has 0.35% invested in Gilead Sciences, Inc. (NASDAQ:GILD). State Of Wisconsin Investment Board invested 0.44% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Bahl & Gaynor stated it has 23,816 shares. Manchester Capital Mngmt Ltd Liability Corporation reported 12,241 shares. Da Davidson & Company stated it has 0.13% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Woodley Farra Manion Portfolio Mgmt Inc accumulated 358,413 shares. First Heartland Consultants reported 3,046 shares or 0.07% of all its holdings.

Muhlenkamp & Co Inc, which manages about $560.67 million and $275.65M US Long portfolio, decreased its stake in Microsoft Corp (NASDAQ:MSFT) by 66,041 shares to 162,821 shares, valued at $14.86 million in 2018Q1, according to the filing. It also reduced its holding in Gilead Sciences Inc Com (Call) (NASDAQ:GILD) by 22,500 shares in the quarter, leaving it with 2,200 shares, and cut its stake in Apple Computer Inc. (NASDAQ:AAPL).

Investors sentiment decreased to 0.73 in Q1 2018. Its down 0.20, from 0.93 in 2017Q4. It dived, as 88 investors sold MO shares while 562 reduced holdings. 100 funds opened positions while 372 raised stakes. 1.16 billion shares or 0.04% more from 1.16 billion shares in 2017Q4 were reported. 3,650 are held by Argent Mngmt Limited Liability. Amalgamated Bancshares reported 275,850 shares or 0.46% of all its holdings. Efg Asset Mngmt (Americas) Corporation accumulated 16,482 shares. Mackenzie owns 2.98 million shares. Apriem Advsrs owns 27,923 shares. Reaves W H has invested 0.04% in Altria Group, Inc. (NYSE:MO). Agf Investments America reported 1.47% stake. The Virginia-based Evermay Wealth Mgmt Limited Com has invested 0.28% in Altria Group, Inc. (NYSE:MO). Parsons Cap Incorporated Ri holds 0.05% or 6,202 shares. First Manhattan stated it has 1.13M shares. Advisory Services Net Limited Liability has 83,704 shares for 0.42% of their portfolio. Cetera Advisor Netwr Ltd Liability Co stated it has 0.22% in Altria Group, Inc. (NYSE:MO). Manchester Cap Mgmt Llc owns 0.06% invested in Altria Group, Inc. (NYSE:MO) for 5,562 shares. First Merchants holds 0.06% or 5,600 shares. 9.02M were accumulated by Invesco Ltd.

Analysts await Altria Group, Inc. (NYSE:MO) to report earnings on October, 25. They expect $1.07 earnings per share, up 18.89% or $0.17 from last year’s $0.9 per share. MO’s profit will be $2.02B for 13.80 P/E if the $1.07 EPS becomes a reality. After $1.01 actual earnings per share reported by Altria Group, Inc. for the previous quarter, Wall Street now forecasts 5.94% EPS growth.

Among 20 analysts covering Altria Group Inc. (NYSE:MO), 16 have Buy rating, 0 Sell and 4 Hold. Therefore 80% are positive. Altria Group Inc. had 67 analyst reports since July 31, 2015 according to SRatingsIntel. Stifel Nicolaus maintained it with “Buy” rating and $71 target in Monday, June 27 report. On Tuesday, October 3 the stock rating was maintained by RBC Capital Markets with “Hold”. The firm earned “Hold” rating on Monday, June 5 by Jefferies. Citigroup maintained Altria Group, Inc. (NYSE:MO) rating on Monday, October 30. Citigroup has “Buy” rating and $75 target. The company was maintained on Monday, July 31 by Wells Fargo. The rating was maintained by Stifel Nicolaus with “Buy” on Monday, October 23. The stock of Altria Group, Inc. (NYSE:MO) has “Sector Perform” rating given on Monday, July 31 by RBC Capital Markets. CLSA maintained the stock with “Outperform” rating in Thursday, September 15 report. Morgan Stanley reinitiated it with “Equal-Weight” rating and $65 target in Tuesday, November 29 report. The stock of Altria Group, Inc. (NYSE:MO) has “Hold” rating given on Friday, September 1 by RBC Capital Markets.

More notable recent Altria Group, Inc. (NYSE:MO) news were published by: Seekingalpha.com which released: “Buy Altria: Growing Sin Stock With A 4.7% Dividend Yield” on August 06, 2018, also Seekingalpha.com with their article: “Altria Has Some Work To Do” published on July 30, 2018, Fool.com published: “Altria Claims That Low-Nicotine Cigarettes Could Cost a Million US Jobs” on July 23, 2018. More interesting news about Altria Group, Inc. (NYSE:MO) were released by: Seekingalpha.com and their article: “Dividend Champion Spotlight: Altria Group, Inc.” published on July 15, 2018 as well as Fool.com‘s news article titled: “How Long Can Altria Grow Profits With Falling Sales?” with publication date: August 12, 2018.

Since February 9, 2018, it had 1 buying transaction, and 2 selling transactions for $115,308 activity. Dillard James E III also sold $410,313 worth of Altria Group, Inc. (NYSE:MO) on Friday, February 9. Shares for $199,488 were sold by SURGNER W HILDEBRANDT JR. Newman Mark had bought 5,345 shares worth $300,334.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts